Hamlet Pharma soon to be Hamlet BioPharma presents at Aktiespararnas Capital Market Day on June 12 in Stockholm at 13.30 CET
Lund, June 9, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, invites to investor presentation at Aktiespararnas Capital Market Day on June 12 in Stockholm.
The founder and Chairman Catharina Svanborg will present at 13.30 CET on June 12 at Birger Jarlsgatan 61 A.
Sign up here to participate in Stockholm:
https://www.aktiespararna.se/aktiviteter/smabolagsdagarna-i-stockholm-12-juni
Follow the presentation online here:
www.youtube.com/Aktiespararna.
More information about the event is available on:
https://www.aktiespararna.se/aktiviteter/smabolagsdagarna-i-stockholm-i-juni
Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections, an additional pharmaceutical project with patent rights for the treatment of tuberculosis is acquired.
A warm welcome!
Catharina Svanborg
Phone +46-709-426549
Jan Zetterberg
Phone: +46-705-544300